Home LiteratureArticle Details
PMID: 1449769 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Leber hereditary optic neuropathy in Australia.

Australian and New Zealand journal of ophthalmology ·Vol. 20 ·No. 3 ·1992-08-00 ·Pages 177-84

Mackey DA, Buttery RG

Abstract

Leber hereditary optic neuropathy (LHON) presents with sudden onset of visual loss mainly in young adult males. LHON is not uncommon in Australia, accounting for 2% of invalid blind pensions. We have identified 20 unrelated families carrying mitochondrial DNA mutations associated with LHON and 135 of 291 individuals with documented LHON are currently alive in Australia. The mean age of onset of visual loss for males was 26 years and for females 27 years, with a range from six to 65 years. The mean risk of visual loss was 20% for males and 4% for females. There are over 1750 male and female carriers living in Australia who have not yet lost vision; 600 carriers are under 24 years of age. The expected number of new cases of blindness from LHON is three to four per year.

MeSH Terms
Adolescent Adult Aged Australia/epidemiology Blindness/epidemiology,genetics Child DNA, Mitochondrial/genetics Female Fundus Oculi Humans Male Middle Aged Mutation Optic Atrophies, Hereditary/epidemiology,genetics Pedigree Risk Factors Visual Acuity Visual Fields
Chemicals
DNA, Mitochondrial
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Mackey D A
Department of Ophthalmology, Royal Children's Hospital, Melbourne, Victoria, Australia.
Buttery R G
Article Info
Journal
Australian and New Zealand journal of ophthalmology
Abbr.
Aust N Z J Ophthalmol
ISSN
0814-9763
Published
1992-08-00
Pages
177-84
Language
English
Region
Australia
NLM ID
8505423
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com